BSGM — Biosig Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Biosig Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	28.3	11.7	0.458	0.293	0.155
Net Total Accounts Receivable
Net Total Receivables	—	—	0.009	0.024	0.109
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29.3	13.9	1.13	0.528	0.344
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.595	1.26	1.37	0.921	0.181
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	30.4	15.5	4.11	1.8	0.842
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.11	2.58	3.26	4.58	2.26
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	5.91	3.17	3.69	4.71	2.28
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	24.5	12.3	0.418	-2.91	-1.44
Total Liabilities & Shareholders' Equity	30.4	15.5	4.11	1.8	0.842
Total Common Shares Outstanding
Total Preferred Shares Outstanding